Non-Drug-Eluting Device Market Analysis | 2025-2030

Attractive Opportunities

Global Demand Analysis & Sales Opportunities in Non-Drug-Eluting Device Market

• The annual demand for non-drug-eluting device was USD 7.0 billion in 2024 and is expected to reach USD 7.6 billion in 2025, up 7.9% than the value in 2024.

• During the forecast period (2025 to 2030), the non-drug-eluting device market is expected to grow at a CAGR of 6.4%. The annual demand will reach of USD 10.4 billion in 2030.

• During 2025-2030, the non-drug-eluting device industry is expected to generate a cumulative sales opportunity of USD 54.05 billion.

High-Growth Market Segments:

• North America is expected to maintain its reign and is likely to grow at the fastest rate. 

• By Degradability type, Biodurable is likely to be the dominant type in the market during the forecast period.

• By Application type, Implants are likely to maintain their market dominance in the coming years

• By End-Use type, Hospitals are expected to remain the biggest demand generator in the market during the forecast period.

Market Statistics

Have a look at the sales opportunities presented by the non-drug-eluting device market in terms of growth and market forecast.

Market Dynamics

Introduction:

What is a non-drug-eluting device?

A non-drug-eluting device is a type of medical implant or instrument that performs its intended mechanical or structural function without releasing any drugs or medicinal substances into the body. These devices are designed purely for physical support, repair, or replacement of tissues or organs, unlike drug-eluting devices that deliver therapeutic agents over time to prevent complications like infection or tissue regrowth.

Examples of non-drug-eluting devices include bare-metal stents, orthopedic implants, vascular grafts, and catheters that do not contain or release drugs. Their primary purpose is to restore or maintain physiological function, for instance, keeping blood vessels open, stabilizing bones, or facilitating fluid flow, through mechanical means alone.

Segment Analysis

By Application Type

“Implants are expected to remain the dominant and fastest-growing application type in the market during the forecast period.”

• The global non-drug-eluting device market is segmented into implants and sutures.

• Implants are used in various medical-surgical procedures in the current market and are expected to grow rapidly with increasing cardiovascular, orthopedic, and neurological implants.

• Non-drug-eluting sutures are being increasingly used for surgical incisions in various types of surgeries. They are used to repair skin lacerations and traumatic wounds in the human body and hence are required where permanent sutures are not required.

By Degradability Type

“Biodurable is expected to remain the dominant and fastest-growing degradable type in the market during the forecast period.”

• The market is segmented into biodurable and bioresorbable.

• Biodurable implants are highly used in the market. These implants are designed to serve as mechanical support for a longer duration or indefinitely, depending on the requirements.

• Bioresorbable sutures are mostly used in surgical devices requiring absorption by the body over a certain period.

By End-User Type

“Hospital is expected to be the dominant end-user type, whereas ambulatory surgical centers will be the fastest-growing end-user type during the forecast period.”

• The market is segmented into hospitals and ambulatory surgical centers.

• Hospitals remain a key end-user market with increasing implant procedures in hospitals. Also, sutures continue to be highly used in hospitals.

• Ambulatory surgical centers' strong growth is due to rising demand for urgent sutures in the market.

Regional Analysis

“North America is expected to remain the largest and fastest-growing market for non-drug-eluting devices during the forecast period.”

• North America's dominance in the market is driven by high implant surgeries in the region and the increased demand for biocompatible sutures in the region. The region also has leading manufacturers of non-drug-eluting devices like Medtronic plc. and Johnson & Johnson. The region will show exceptional growth in the coming years, with new medical implants getting approved by the FDA for the market.

• Asia-Pacific is also a strong growth region with new fuelled demand for implant procedures in the region, mainly for orthopedic implants in countries like China and India.

Competitive Landscape

Most of the major players compete in some of the factors, including price, service offerings, regional presence, etc. The following are the key players in the non-drug-eluting device market -  

Here is the list of the Top Players (Based on Dominance)

• B. Braun Melsungen AG

• Boston Scientific Corporation

• ConMed Corporation

• DemeTECH Corporation

• Integra Lifesciences

• Johnson & Johnson Services Inc.

• Medtronic

• Peter Surgical

• Smith & Nephew plc.

• Stryker Corporation

• Teleflex Incorporated

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at [email protected]

Recent Developments/Mergers & Acquisitions:

• In January 2024, Vy Spine obtained FDA clearance for its ClariVy OsteoVy PEKK Cervical IBF, a device intended for intervertebral body fusion at a single cervical spine level (C3 to T1) to address degenerative disc disease. It incorporates Vy Spine's distinctive OsteoVy lattice structure and the osseointegration OXPEKK material.

• In February 2020, Bioretec Limited was awarded CE certification for its Activa IM-Nail™ bioabsorbable intramedullary nail. These implants have demonstrated exceptional performance in repairing the growing bones of children and young individuals.

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept so that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.

The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.

• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.

• Market trend and forecast analysis.

• Market segment trend and forecast.

• Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.

• COVID-19 impact and its recovery curve.

• Attractive market segments and associated growth opportunities.

• Emerging trends.

• Strategic growth opportunities for the existing and new players.

• Key success factors.

Market Segmentation

The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The non-drug-eluting device market is segmented into the following categories. 

By Application Type 

• Implants

• Sutures

By Degradability Type 

• Biodurable

• Bioresorbable

By End-User Type 

• Hospitals

• Ambulatory Surgical Centers

By Region

• North America (Country Analysis: The USA, Canada, and Mexico)

• Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)

• Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific)

• Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others)

Research Methodology

• This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s global non-drug-eluting device market realities and future market possibilities for the forecast period. 

• The report segments and analyzes the market in the most detailed manner to provide a panoramic view of the market.

• The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.

• This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

• More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.

• We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Service portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected]